Nasus Pharma (NSRX) P/B (2025 - 2026)
Nasus Pharma (NSRX) P/B from Aug 13, 2025 to Jul 20, 2026. The TTM Nasus Pharma (NSRX) P/B is 9.80. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Nasus Pharma (NSRX)
| Year | P/B | Change |
|---|---|---|
| 2026 | 9.80 | -67.10% |
| 2025 | 29.78 | N/A |
Comparison Nasus Pharma (NSRX) P/B with competitors
Nasus Pharma (NSRX) P/B is 9.80.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -93.02% |
| GRFS | Grifols SA | 0.79 | -91.94% |
| SNY | Sanofi | 1.27 | -87.04% |
| BIIB | Biogen Inc | 1.52 | -84.49% |
| PFE | Pfizer Inc | 1.55 | -84.20% |
| OGN | Organon & Company | 3.93 | -59.92% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -58.24% |
| GSK | GSK Plc | 4.37 | -55.37% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -38.35% |
| AZN | Astrazeneca plc | 6.20 | -36.71% |
| MRK | Merck & Co Inc | 6.68 | -31.81% |
| GILD | Gilead Sciences Inc | 6.94 | -29.16% |
| NVO | Novo Nordisk | 7.07 | -27.83% |
| NVS | Novartis AG | 7.60 | -22.42% |
| JNJ | Johnson & Johnson | 7.64 | -22.01% |
| MDCX | MDCorp | 15.34 | +56.59% |
| AMGN | AMGEN Inc | 21.17 | +116.10% |
| SCLX | Scilex Holding Company | 28.85 | +194.49% |
| LLY | Lilly(Eli) & Company | 32.94 | +236.24% |
| ABBV | Abbvie Inc | 50.46 | +415.08% |